American National Bank & Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
SIM
NONA
NO
FFM
BCAM
MIM
American National Bank & Trust's EW Position: Q3 2026 in Review
American National Bank & Trust reduced its Edwards Lifesciences (EW) stake by 5.8% in Q3 2026, selling an estimated $7.91K and leaving 1,438 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #280.
American National Bank & Trust first reported a position in EW in Q4 2021 and has held it in 20 quarters since. The position peaked at $161K in Q1 2024. 153 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- American National Bank & Trust held 1,438 shares of Edwards Lifesciences worth $124K as of Q3 2026.
- American National Bank & Trust sold 89 Edwards Lifesciences shares in Q3 2026, an estimated $7.91K.
- Edwards Lifesciences made up 0.01% of American National Bank & Trust's portfolio in Q3 2026, its #280 holding.
- American National Bank & Trust first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 20 quarters since.
- American National Bank & Trust's Edwards Lifesciences position peaked at $161K in Q1 2024.
- 153 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on American National Bank & Trust's 13F filing for Q3 2026, filed 7 Oct 2026.